OBFC1

The Chromosome Guardian — OBFC1 and the Telomere Length Paradox

Your chromosomes end in telomeres — repetitive DNA caps that protect genetic information from fraying
like the plastic tips on shoelaces. Every time a cell divides, telomeres shorten slightly, acting as
a molecular clock that limits how many times a cell can replicate. When telomeres reach a critical
short length, cells enter senescence or die, a process thought to drive much of what we call aging.
The OBFC1 gene encodes [STN1 | Suppressor of cdc Thirteen 1], a subunit of the CST complex
(CTC1-STN1-TEN1) that caps telomere ends, recruits DNA polymerase alpha for C-strand fill-in synthesis,
and counterbalances telomerase to prevent runaway telomere elongation. The rs9420907 variant sits in
an intron of OBFC1 and affects how efficiently this capping mechanism operates — with consequences
running in two directions at once.

The Mechanism

Rs9420907 is an intronic regulatory variant at 10q24.33 within OBFC1, located on the forward strand
at GRCh38 position 103,916,707. It does not alter the STN1 protein directly, but sits in a region
assigned a RegulomeDB score of 3a — indicating probable transcription factor binding site activity
in a DNase I-hypersensitive region. Altered transcription factor affinity likely modulates OBFC1
mRNA levels, which in turn shifts the balance of the CST complex at telomere ends.

When OBFC1/STN1 levels are reduced (A-allele pattern), CST-mediated C-strand fill-in is less
efficient after each round of telomerase extension. The result: telomeres grow shorter faster.
Depletion of hSTN1 in human somatic cells | Huang C et al. Human Stn1 protects telomere integrity
by promoting efficient lagging-strand synthesis at telomeres. Cell Research, 2012 causes catastrophic telomere shortening, DNA damage
response activation, and premature cellular senescence — a cellular blueprint for accelerated aging.
The C allele appears to maintain or increase OBFC1 expression, preserving telomere length but
also — paradoxically — allowing cancer cells greater replicative freedom.

The Evidence

The original GWAS discovery | Levy D et al. Genome-wide association identifies OBFC1 as a locus
involved in human leukocyte telomere biology. PNAS, 2010 in 3,417 participants identified rs9420907 as
genome-wide significant (P = 2.0×10⁻⁸), with the A allele coding for shorter leukocyte telomere
length (β = −0.11 standard deviations per allele, equivalent to approximately 83 base pairs).

The finding was powerfully confirmed in a meta-analysis of 37,684 individuals | Codd V et al.
Identification of seven loci affecting mean telomere length and their association with disease.
Nature Genetics, 2013. OBFC1 emerged as one of
five confirmed telomere-biology loci, alongside TERT, TERC, NAF1, and RTEL1 — each encoding
a protein directly involved in telomere maintenance. The seven-locus genetic risk score for
shorter telomeres was associated with a 21% increase in coronary artery disease risk per standard
deviation reduction in telomere length (P = 0.014, across 22,233 cases and 64,762 controls).

The paradox deepens with cancer data. The C allele | Speedy HE et al. Genetic variation
associated with longer telomere length increases risk of CLL. Cancer Epidemiology, Biomarkers
& Prevention, 2016 — which gives longer telomeres
— increases CLL risk (OR 1.36, 95% CI 1.08–1.71), and a separate study found
OBFC1-rs9420907-C associates with myeloproliferative neoplasm risk | Cordone I et al.
Genetic polymorphisms and MPN risk. Blood Cancer Journal, 2020 with an OR of 1.43 (95% CI 1.15–1.77), and
with multiple myeloma risk (OR 1.32, 95% CI 1.12–1.55). This mirrors the pattern seen at
the TERT locus: longer telomeres protect against degenerative aging but allow cancer cells
to replicate unchecked.

Crucially, rs9420907 shows extreme population stratification. The C allele is present at
~14% in Europeans and ~15% in Latinos, but reaches ~53% in African populations and is nearly
absent (~1.6%) in East Asians — where the locus is effectively monomorphic. This means the
variant's effects on aging and disease risk are most relevant for people of European and
African descent.

Practical Implications

For AA homozygotes (short-telomere genotype), the key concern is accelerated cellular aging:
shorter average leukocyte telomere length at any given age, modestly elevated cardiovascular
disease risk, and the general health consequences of faster biological clock ticking. The
actionable response is to preserve telomere length through lifestyle: aerobic exercise has
the most consistent evidence for telomere preservation, alongside adequate omega-3 intake,
stress reduction, and avoidance of smoking and excess alcohol.

For C-allele carriers, the picture is more nuanced. Longer telomeres are generally protective
against age-related disease, but carriers of one or two C alleles face modestly elevated risk
for hematologic malignancies (CLL, MPN, multiple myeloma). This does not warrant alarm —
the absolute risk increase is small — but it supports attentiveness to unexplained fatigue,
lymphadenopathy, or abnormal blood counts, and adherence to standard cancer screening protocols.

Interactions

OBFC1 rs9420907 operates within the broader telomere-length regulatory network. The strongest
pathway partners are rs2736100 in TERT | the telomerase catalytic subunit,
rs16847897 in TERC | the telomerase RNA template, and
rs12696304 in TERC | second independent TERC signal. These loci act additively
— people who inherit short-telomere alleles at multiple loci have substantially shorter
telomeres than those with only one variant, and correspondingly higher cardiovascular risk.

The FOXO3 longevity variant rs2802292 | the most replicated human longevity locus
is mechanistically connected: FOXO3 G-allele carriers show higher telomerase activity and
better telomere protection with age, suggesting FOXO3 may partially compensate for short-telomere
genotypes at OBFC1 and TERT. No formal interaction study has tested this combination, but the
mechanistic overlap is plausible and worth investigating in future research.